Abstract
We investigated the effect of bergamottin, a major furanocoumarin in grapefruit juice, on phase I and phase II drug-metabolizing enzymes using cultured human and monkey hepatocytes. Both cultured systems were compared and evaluated for the direct effects of bergamottin as well as control treatments on liver enzymes. Treatment of hepatocytes with 0.1, 1, 5, and 10 μM bergamottin resulted in a concentration-dependent reduction in CYP3A4 activity (40–100%) in both human and monkey cells, as measured by testosterone 6β-hydroxylase activity. Bergamottin was potent at eliciting these inhibitory effects at both basal and induced states of CYP3A. Bergamottin (5 μM) completely inhibited α-naphthoflavone-induced ethoxyresorufinO-dealkylase (EROD) and methoxyresorufinO-dealkylase (MROD) activities in human hepatocytes and caused a 100% decrease in EROD activity in monkey hepatocytes. A 48-h exposure of cultured human hepatocytes to bergamottin resulted in increased levels of immunoreactive CYP3A4, CYP1A1, and CYP1A2 proteins, and CYP3A4, CYP1A1, CYP1A2, CYP2B6, and UDP-glucuronosyl transferase mRNAs. There was only a 20 to 30% reduction in glucuronidation and sulfation of 4-methylumbelliferone in human hepatocytes by 10 μM bergamottin and no effect on conjugation in the monkey hepatocytes. These results suggest that bergamottin causes both inhibition of CYP3A and CYP1A1/2 enzymatic activities and induction of correspondent proteins and mRNAs.
Footnotes
-
This work was supported in part by Grants GM 61393, GM 60346, ESO 5780, and DK 92310 to Stephen C. Strom.
- Abbreviations used are::
- AUC
- area under the curve
- P450
- cytochrome P-450
- 4-MU
- 4-methylumbelliferone
- SSC
- standard saline citrate
- TAO
- triacetyloleandomycin
- β-NF
- β-naphthoflavone
- HPLC
- high-performance liquid chromatography
- EROD
- ethoxyresorufin O-dealkylase
- MROD
- methoxyresorufinO-dealkylase
- DMSO
- dimethyl sulfoxide
- 3MC
- 3-methylcholanthrene
- Received March 21, 2002.
- Accepted May 29, 2002.
- U.S. Government
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
